ARROWHEAD PHARMACEUTICALS, INC. Deferred Tax Liabilities, Property, Plant and Equipment
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Deferred Tax Liabilities, Property, Plant and Equipment of $30.50 million as of 2025-09-30, per its 10-K filed 2025-11-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2025-11-25
- 2025-09-30: Deferred Tax Liabilities, Property, Plant and Equipment $30.50M.
- 2024-09-30: Deferred Tax Liabilities, Property, Plant and Equipment $13.15M.
- 2023-09-30: Deferred Tax Liabilities, Property, Plant and Equipment $9.88M.
- 2022-09-30: Deferred Tax Liabilities, Property, Plant and Equipment $1.09M.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment | Deferred Tax Liabilities, Property, Plant and Equipment as first filed |
|---|---|---|
| 2025-09-30 | $30.50M 10-K · filed 2025-11-25 | |
| 2024-09-30 | $13.15M 10-K · filed 2025-11-25 | |
| 2023-09-30 | $9.88M 10-K · filed 2024-11-26 | |
| 2022-09-30 | $1.09M 10-K · filed 2023-11-29 | |
| 2021-09-30 | $6.36M 10-K · filed 2022-11-28 | |
| 2020-09-30 | $2.55M 10-K · filed 2021-11-22 | $2.55M 10-K · filed 2020-11-23 |
| 2016-09-30 | $38.95K 10-K · filed 2017-12-12 | |
| 2015-09-30 | $84.71K 10-K · filed 2016-12-14 | |
| 2014-09-30 | $241.48K 10-K · filed 2015-12-14 | -$241.48K 10-K · filed 2014-11-25 |
| 2013-09-30 | -$544.02K 10-K · filed 2014-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |